ML230 is primarily utilized in biochemical research for its role as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH). By inhibiting sEH, ML230 helps in studying the biological pathways involving epoxyeicosatrienoic acids (EETs), which are known to play significant roles in cardiovascular and inflammatory processes. This makes ML230 a valuable tool in preclinical studies aimed at understanding and potentially treating conditions such as hypertension, atherosclerosis, and chronic pain. Additionally, its application extends to investigating the protective effects of EETs in various organ systems, including the heart, kidneys, and brain, thereby contributing to the development of novel therapeutic strategies.